Cloning of two new splice variants of Siglec-10 and mapping of the interaction between Siglec-10 and SHP-1

被引:31
作者
Kitzig, F [1 ]
Martinez-Barriocanal, A [1 ]
López-Botet, M [1 ]
Sayós, J [1 ]
机构
[1] Univ Pompeu Fabra, DCEXS, Mol Immunopathol Unit, Barcelona, Spain
关键词
inhibitory receptors; Siglec; SHP-1; SH2d1A; sialic acid;
D O I
10.1016/S0006-291X(02)00885-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Using a three-hybrid strategy in yeast. we have cloned a new splice variant of Siglec-10, called Siglec-10 Sv3. This splice variant lacks part of exon 3. but keeps the reading frame, as well as the crucial regions for interaction with Sias and the motifs for intracellular signaling. The expression of Siglec-10 Sv3 in T- and B-cells was detected by RT-PCR. Moreover, CDNA of another new splicing form of Siglec-10, named Siglec-10 Sv4. was identified by RT-PCR. One common characteristic of all Siglec-10 splice forms (except for Siglec-10 Sv2) is their cytoplasmic tail with two ITIMs and one CD150-like sequence. We confirmed the recruitment of SHP-1 to the Siglec-10 cytoplasmic tail by Western blot analysis and demonstrated that this interaction depends on tyrosine phosphorylation. Mutational analyses showed that ITIM Y609 of Siglec-10 and the N-terminal SH2 domain of SHP-1 play a pivotal role in the interaction between Siglec-10 and SHP-1. Finally, we demonstrated that Siglec-10 was not able to bind SAP/SH2d1A, indicating that the so-called CD150-like motif in Siglec-10 might be a docking site for other signal transduction mediators. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:355 / 362
页数:8
相关论文
共 30 条
[1]  
ANGATA T, 2002, J BIOL CHEM
[2]  
ARAMBURU J, 1990, J IMMUNOL, V144, P3238
[3]   Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A [J].
Aramburu, J ;
Yaffe, MB ;
López-Rodríguez, C ;
Cantley, LC ;
Hogan, PG ;
Rao, A .
SCIENCE, 1999, 285 (5436) :2129-2133
[4]   Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor [J].
Bellón, T ;
Kitzig, F ;
Sayós, J ;
López-Botet, M .
JOURNAL OF IMMUNOLOGY, 2002, 168 (07) :3351-3359
[5]   A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells [J].
Colonna, M ;
Nakajima, H ;
Navarro, F ;
López-Botet, M .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (03) :375-381
[6]   A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells [J].
Colonna, M ;
Navarro, F ;
Bellon, T ;
Llano, M ;
Garcia, P ;
Samaridis, J ;
Angman, L ;
Cella, M ;
LopezBotet, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (11) :1809-1818
[7]   Molecular analysis of sialoside binding to sialoadhesin by NMR and site-directed mutagenesis [J].
Crocker, PR ;
Vinson, M ;
Kelm, S ;
Drickamer, K .
BIOCHEMICAL JOURNAL, 1999, 341 :355-361
[8]   Siglecs, sialic acids and innate immunity [J].
Crocker, PR ;
Varki, A .
TRENDS IN IMMUNOLOGY, 2001, 22 (06) :337-342
[9]   Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells [J].
Falco, M ;
Biassoni, R ;
Bottino, C ;
Vitale, M ;
Sivori, S ;
Augugliaro, R ;
Moretta, L ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (06) :793-801
[10]   A 'three-pronged' binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome [J].
Hwang, PM ;
Li, CJ ;
Morra, M ;
Lillywhite, J ;
Muhandiram, DR ;
Gertler, F ;
Terhorst, C ;
Kay, LE ;
Pawson, T ;
Forman-Kay, JD ;
Li, SC .
EMBO JOURNAL, 2002, 21 (03) :314-323